FONDAZIONE PENTA ONLUS - IT 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 5
As coordinator: 0
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 990.432 0 1
2021 0 33.523.401 4.443.664 4
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITEIT ANTWERPEN3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
STELLENBOSCH UNIVERSITY2
UNIVERSITA DEGLI STUDI DI PADOVA2
AGENCE NATIONALE DE LA RECHERCHE1
ARISTOTELIAN UNIVERSITY OF THESSALONIKI1
ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOCRUCES BIZKAIA1
ASPHALION SL1
ASTRAZENECA1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHIANG MAI UNIVERSITY1
CONENO1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
DEUTSCHES ZENTRUM FUR LUFT UND RAUMFAHRT EV1
EUROPEAN AIDS TREATMENT GROUP EV1
EUROPEAN PUBLIC HEALTH ALLIANCE1
FONDAZIONE BRUNO KESSLER1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DOCTOR JOSEP TRUETA1
FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDACAIXA1
FUNDACION FILS DE LUCHA CONTRA ELSIDA LAS ENFERMEDADES INFECCIOSASY LA PROMOCION DE LA SALUD Y LACIENCIA1
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA1
GLAXOSMITHKLINE BIOLOGICALS1
HIPRA HUMAN HEALTH SL1
HIPRA SCIENTIFIC SL1
HOSPITAL CLINIC DE BARCELONA1
ICARS1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUTO DE SALUD CARLOS III1
ISTITUTO PER L'INTERSCAMBIO SCIENTIFICO1
ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE1
JANSSEN PHARMACEUTICA NV1
KNOWLEDGE TRANSFER NETWORK LIMITED1
LABORATORIOS HIPRA1
LES CENTRES GHESKIO1
LIETUVOS MOKSLO TARYBA1
MAHIDOL UNIVERSITY1
MARTINLUTHERUNIVERSITAT HALLEWITTENBERG1
METPHARM ARASTIRMA GELISTIRME SAGLIK DANISMANLIK LIMITED SIRKET1
MINISTERO DEL LAVORO DELLA SALUTE E DELLE POLITICHE SOCIALI1
MINISTRY OF HEALTH1
MOR RESEARCH APPLICATIONS1
NOVAVAX INC1
PFIZER LIMITED1
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU1
SANOFIAVENTIS1
SERVICIO VASCO DE SALUD OSAKIDETZA1
SERVIZO GALEGO DE SAUDE1
ST GEORGE'S HOSPITAL MEDICAL SCHOOL1
STATENS SERUM INSTITUT1
STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG1
STICHTING RESVINET1
SWISS TROPICAL INSTITUTE1
TARTU ULIKOOL1
TEAM IT RESEARCH SL1
TERVEYDEN JA HYVINVOINNIN LAITOS1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE UNIVERSITY OF EDINBURGH1
UNITED KINGDOM RESEARCH AND INNOVATION1
UNIVERSITA DEGLI STUDI DI VERONA1
UNIVERSITAET BASEL1
UNIVERSITAET ZUERICH1
UNIVERSITATSKINDERSPITAL BEIDER BASEL1
UNIVERSITEIT HASSELT1
UNIVERSITY COLLEGE LONDON1
UNIVERSITY OF CAPE TOWN1
UNIVERSITY OF FLORIDA1
UNIVERSITY OF OSLO1
VARSINAISSUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA1
VERISTAT INTERNATIONAL LIMITED1
VETENSKAPSRADET SWEDISH RESEARCH COUNCIL1
VINCES CONSULTING SL1
ZABALA INNOVATION CONSULTING S A1
ZORGONDERZOEK NEDERLAND ZON1

Constancy:

Total number of partners: 82
Partner loyalty:
Frequent Partner: (> 2 projects): 6
Rare Partner: 76
Frequent / Rare Partner Ratio: 0.08

Project overview:

Start dateProjectacronymrolefundingpartners
2022-05-01DESIGNing the European Partnership on One Health AMR DESIGN OH AMRparticipant990.43213
2021-12-01RBD Dimer recombinant protein vaccine against SARSCoV2 RBDCOVparticipant9.779.21116
2021-11-01Preparing for RSV Immunisation and Surveillance in Europe PROMISEparticipant3.744.37522
2021-11-01SARS-coV2 variants Evaluation in pRegnancy and paeDIatrics cohorts VERDIparticipant9.999.99823
2021-04-01Establishing innovative approaches for optimal infection prevention of resistant bacteria in NICUs by integrating research, implementation science and surveillance in a sustainable global platform NeoIPCparticipant9.999.81713